Stock Events

Hercules Capital 

$24.84
2461
+$0.01+0.04% Friday 19:53

Estadísticas

Día Alto
24.92
Día de baja
24.84
52W Alto
25.88
52W Bajo
22
Volumen
1,957
Volumen medio
1,198
Cap. de mercado
3.42B
Relación P/U
11.29
Rentabilidad por dividendo
6.29%
Dividendo
1.56

Próximamente

Dividendos

6.29%Rentabilidad por dividendo
Tasa de crecimiento en 10 años
No aplica
Tasa de crecimiento en 5 años
24.57%
Tasa de crecimiento en 3 años
-9.14%
Tasa de crecimiento en 1 año
-25%

Ganancias

2MayConfirmado
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
0.36
0.43
0.49
0.56
GPA esperado
0.5
GPA actual
0.5

La gente también sigue a

Esta lista se basa en las watchlists de personas que siguen a HCXY en Stock Events. Esto no es una recomendación de inversión.

Competidores

Esta lista es un análisis basado en eventos recientes del mercado. No es una recomendación de inversión.
Ares Capital
ARCC
Cap. de mercado13.02B
Ares Capital Corporation es un competidor líder en el espacio de las compañías de desarrollo empresarial (BDC), ofreciendo servicios financieros similares e inversiones en empresas de mediano tamaño.
Golub Capital BDC
GBDC
Cap. de mercado2.72B
Golub Capital BDC, Inc. ofrece soluciones de financiamiento para empresas de mediano tamaño, compitiendo directamente con Hercules Capital en el mismo sector.
Prospect Capital
PSEC
Cap. de mercado2.32B
Prospect Capital Corporation opera como una BDC, invirtiendo en empresas privadas y empresas públicas de microcapitalización, lo que la convierte en un competidor directo de Hercules Capital.
Main Street Capital
MAIN
Cap. de mercado4.41B
Main Street Capital Corporation es una firma de inversión principal que se enfoca en estrategias de inversión similares a las de Hercules Capital, dirigidas a empresas de mercado medio inferior.
TriplePoint Venture Growth BDC
TPVG
Cap. de mercado311.47M
TriplePoint Venture Growth BDC Corp. se especializa en inversiones en etapas de crecimiento de empresas, compitiendo estrechamente con el enfoque de Hercules Capital en empresas innovadoras y tecnológicas.
FS KKR Capital
FSK
Cap. de mercado5.69B
FS KKR Capital Corp. es una BDC que compite con Hercules Capital ofreciendo soluciones de crédito personalizadas a empresas privadas de tamaño medio en Estados Unidos.
Oaktree Specialty Lending
OCSL
Cap. de mercado1.51B
Oaktree Specialty Lending Corporation es un competidor en el mercado de BDC, enfocándose en proporcionar soluciones de financiamiento flexibles a empresas de mediano tamaño.
BlackRock TCP Capital
TCPC
Cap. de mercado942.36M
BlackRock TCP Capital Corp. es un competidor directo, que proporciona financiamiento de deuda y capital propio a empresas de mediano tamaño, de manera similar al enfoque de inversión de Hercules Capital.
New Mountain Finance
NMFC
Cap. de mercado1.34B
New Mountain Finance Corporation compite en el espacio de BDC al centrarse en valores de deuda y préstamos a empresas de mediana capitalización, al igual que la estrategia de Hercules Capital.
Sixth Street Specialty Lending
TSLX
Cap. de mercado2.03B
TPG Specialty Lending, Inc. ofrece préstamos directos y soluciones de financiamiento a empresas de mediano tamaño, compitiendo en el mismo nicho que Hercules Capital.

Acerca de

Finance
Investment Managers
Finance and Insurance
Securities and Commodity Exchanges
Hercules Capital, Inc. is a business development company. The firm specializing in providing venture debt, debt, senior secured loans, and growth capital to privately held venture capital-backed companies at all stages of development from startups, to expansion stage including select publicly listed companies and select special opportunity lower middle market companies that require additional capital to fund acquisitions, recapitalizations and refinancing and established-stage companies. The firm provides growth capital financing solutions for capital extension; management buy-out and corporate spin-out financing solutions; company, asset specific, or intellectual property acquisition financing; convertible, subordinated and/or mezzanine loans; domestic and international corporate expansion; vendor financing; revenue acceleration by sales and marketing development, and manufacturing expansion. It provides asset-based financing with a focus on cash flow; accounts receivable facilities; equipment loans or leases; equipment acquisition; facilities build-out and/or expansion; working capital revolving lines of credit; inventory. The firm also provides bridge financing to IPO or mergers and acquisitions or technology acquisition; dividend recapitalizations and other sources of investor liquidity; cash flow financing to protect against share price volatility; competitor acquisition; pre-IPO financing for extra cash on the balance sheet; public company financing to continue asset growth and production capacity; short-term bridge financing; and strategic and intellectual property acquisition financings. It also focuses on customized financing solutions, emerging growth, mid venture, and late venture financing. The firm invests primarily in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. The firm generally seeks to invest in companies that have been operating for at least six to 12 months prior to the date of their investment. It prefers to invest in technology, energy technology, sustainable and renewable technology, and life sciences. Within technology the firm focuses on advanced specialty materials and chemicals; communication and networking, consumer and business products; consumer products and services, digital media and consumer internet; electronics and computer hardware; enterprise software and services; gaming; healthcare services; information services; business services; media, content and information; mobile; resource management; security software; semiconductors; semiconductors and hardware; and software sector. Within energy technology, it invests in agriculture; clean technology; energy and renewable technology, fuels and power technology; geothermal; smart grid and energy efficiency and monitoring technologies; solar; and wind. Within life sciences, the firm invests in biopharmaceuticals; biotechnology tools; diagnostics; drug discovery, development and delivery; medical devices and equipment; surgical devices; therapeutics; pharma services; and specialty pharmaceuticals. It also invests in educational services. The firm invests primarily in United States based companies and considers investment in the West Coast, Mid-Atlantic regions, Southeast and Midwest; particularly in the areas of software, biotech and information services. The firm prefers to invest between $10 million and $250 million in equity per transactions. It invests generally between $1 million and $40 million in companies focused primarily on business services, communications, electronics, hardware, and healthcare services. The firm invests primarily in private companies but also have investments in public companies. For equity investments, the firm seeks to represent a controlling interest in its portfolio companies which may exceed 25% of the voting securities of such companies. The firm seeks to invest a limited portion of its assets in equipment-based loans to early-stage prospective portfolio companies. These loans are generally for amounts up to $3 million but may be up to $15 million for certain energy technology venture investments. The firm allows certain debt investments have the right to convert a portion of the debt investment into equity. It also co-invests with other private equity firms. The firm seeks to exit its investments through initial public offering, a private sale of equity interest to a third party, a merger or an acquisition of the company or a purchase of the equity position by the company or one of its stockholders. The firm has structured debt with warrants which typically have maturities of between two and seven years with an average of three years; senior debt with an investment horizon of less than three years; equipment loans with an investment horizon ranging from three to four years; and equity related securities with an investment horizon ranging from three to seven years. The firm prefers to invest through its balance sheet capital. The firm formerly known as Hercules Technology Growth Capital, Inc. Hercules Capital, Inc. was founded in December 2003 and is based in Palo Alto, California with additional offices in North America and Europe.
Show more...
Director general
Scott Bluestein
Empleados
100
País
US
ISIN
US4270968476

Listados